These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24499209)

  • 1. Effect of multisite botulinum toxin injections on gait quality in adults with cerebral palsy.
    Marchiori C; Roche N; Vuillerme N; Zory R; Pradon D
    Disabil Rehabil; 2014; 36(23):1971-4. PubMed ID: 24499209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.
    Wissel J; Heinen F; Schenkel A; Doll B; Ebersbach G; Müller J; Poewe W
    Neuropediatrics; 1999 Jun; 30(3):120-4. PubMed ID: 10480205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
    Balaban B; Tok F; Tan AK; Matthews DJ
    Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults.
    Robertson JV; Pradon D; Bensmail D; Fermanian C; Bussel B; Roche N
    Gait Posture; 2009 Jan; 29(1):108-12. PubMed ID: 18771925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of gait parameters to predict the effectiveness of botulinum toxin injection in the spastic rectus femoris muscle of stroke patients with stiff knee gait.
    Roche N; Boudarham J; Hardy A; Bonnyaud C; Bensmail B
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):361-70. PubMed ID: 25213306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study.
    van der Houwen LE; Scholtes VA; Becher JG; Harlaar J
    Gait Posture; 2011 Feb; 33(2):147-51. PubMed ID: 21190858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of rhythmic auditory stimulation and neurodevelopmental treatment/Bobath on gait patterns in adults with cerebral palsy: a randomized controlled trial.
    Kim SJ; Kwak EE; Park ES; Cho SR
    Clin Rehabil; 2012 Oct; 26(10):904-14. PubMed ID: 22308559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
    Dursun N; Dursun E; Alican D
    Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in electromyographic activity after botulinum toxin injection of the rectus femoris in patients with hemiparesis walking with a stiff-knee gait.
    Boudarham J; Hameau S; Pradon D; Bensmail D; Roche N; Zory R
    J Electromyogr Kinesiol; 2013 Oct; 23(5):1036-43. PubMed ID: 23928281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy.
    Camargo CH; Teive HA; Zonta M; Silva GC; Oliveira MR; Roriz MM; Brandi IV; Becker N; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2009 Mar; 67(1):62-8. PubMed ID: 19330214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
    Lee JH; Sung IY; Yoo JY; Park EH; Park SR
    J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O; Basaran A; Ayoglu H
    J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
    Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
    Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
    J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.